Zhitong Finance App News, Huayuan Biotech (300401.SZ) issued an announcement. Recently, the company and Guangzhou National Laboratory signed the “25-hydroxycholesterol New Drug Research and Development Project Cooperation Agreement”. The two sides agreed to cooperate to promote the research, registration, production and commercialization of broad-spectrum antiviral drugs such as 25-hydroxycholesterol and its precursor drugs by initiating the establishment of a joint venture. The candidate drug has significant market potential in the field of broad-spectrum antiviral drugs. The joint venture is led by the company for subsequent operations and holds no less than 51% of the shares.

Zhitongcaijing · 2d ago
Zhitong Finance App News, Huayuan Biotech (300401.SZ) issued an announcement. Recently, the company and Guangzhou National Laboratory signed the “25-hydroxycholesterol New Drug Research and Development Project Cooperation Agreement”. The two sides agreed to cooperate to promote the research, registration, production and commercialization of broad-spectrum antiviral drugs such as 25-hydroxycholesterol and its precursor drugs by initiating the establishment of a joint venture. The candidate drug has significant market potential in the field of broad-spectrum antiviral drugs. The joint venture is led by the company for subsequent operations and holds no less than 51% of the shares.